A detailed history of Next Capital Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Next Capital Management LLC holds 3,303 shares of JNJ stock, worth $517,679. This represents 0.22% of its overall portfolio holdings.

Number of Shares
3,303
Previous 3,694 10.58%
Holding current value
$517,679
Previous $539,000 0.74%
% of portfolio
0.22%
Previous 0.23%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$145.48 - $167.38 $56,882 - $65,445
-391 Reduced 10.58%
3,303 $535,000
Q2 2024

Aug 20, 2024

BUY
$144.38 - $157.78 $48,511 - $53,014
336 Added 10.01%
3,694 $539,000
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $204,269 - $214,165
1,316 Added 64.45%
3,358 $531,000
Q4 2023

Jan 19, 2024

BUY
$145.6 - $158.88 $297,315 - $324,432
2,042 New
2,042 $320,000
Q4 2022

Jan 12, 2023

SELL
$160.2 - $179.79 $4,645 - $5,213
-29 Reduced 1.67%
1,705 $301,000
Q3 2022

Oct 14, 2022

SELL
$161.33 - $179.52 $64,532 - $71,808
-400 Reduced 18.74%
1,734 $283,000
Q2 2022

Jul 20, 2022

BUY
$168.19 - $186.01 $4,877 - $5,394
29 Added 1.38%
2,134 $378,000
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $9,355 - $10,380
-60 Reduced 2.77%
2,105 $360,000
Q2 2021

Oct 19, 2021

SELL
$159.48 - $171.07 $46,249 - $49,610
-290 Reduced 11.81%
2,165 $357,000
Q1 2021

Apr 30, 2021

BUY
$153.07 - $170.48 $54,033 - $60,179
353 Added 16.79%
2,455 $403,000
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $52,101 - $59,804
-380 Reduced 15.31%
2,102 $331,000
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $42,075 - $48,325
-330 Reduced 11.74%
2,482 $362,000
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $41,004 - $45,911
-323 Reduced 10.3%
2,812 $364,000
Q2 2019

Aug 02, 2019

BUY
$131.15 - $144.24 $326,563 - $359,157
2,490 Added 386.05%
3,135 $437,000
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $79,231 - $95,356
645 New
645 $83,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Next Capital Management LLC Portfolio

Follow Next Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Capital Management LLC with notifications on news.